Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has reported Operating Leases for 6 consecutive years, with $2000.0 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Operating Leases fell 99.88% year-over-year to $2000.0 in Q4 2024; TTM through Dec 2024 was $2000.0, a 99.88% decrease from a year earlier, with the FY2024 full-year figure at $2000.0, down 99.88% from the prior year.
• Operating Leases was $2000.0 for Q4 2024 at Iradimed, down from $2831.0 in the prior quarter.
• Over five years, Operating Leases peaked at $2.7 million in Q1 2020 and troughed at $2000.0 in Q4 2024.
• A 5-year average of $1.8 million and a median of $2.0 million in 2022 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases retreated 8.44% in 2020 and plunged 99.88% in 2024, its largest moves.
• Over 5 years, Operating Leases stood at $2.5 million in 2020, then fell by 10.32% to $2.2 million in 2021, then declined by 13.32% to $1.9 million in 2022, then decreased by 15.52% to $1.6 million in 2023, then sank by 99.88% to $2000.0 in 2024.
• The last three Operating Leases figures came in at $2000.0 (Q4 2024), $2831.0 (Q3 2024), and $4231.0 (Q2 2024), per Business Quant data.